Immunization, Hib3 (% of children ages 12-23 months) in Laos
Laos: Immunization, Hib3 (% of children ages 12-23 months) was 67.0% in 2024. ▼ Falling
Immunization, Hib3 in Laos, 2010–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
In 2024, immunization, hib3 in Laos stood at 67.0%.
Compared with earlier readings it is down 9.5% on the previous year and down 19.3% over ten years.
Over the whole period, immunization, hib3 in Laos peaked at 83.0% in 2013 and was at its lowest, 61.0%, in 2020.
That places Laos 174th out of 191 countries with data for 2024, putting it in the bottom quarter.
The long-run direction has been consistently falling across the 15 years of available data.
Immunization, Hib3 (% of children ages 12-23 months) in Laos, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2010 | 74.0% | — |
| 2011 | 76.0% | +2.7% |
| 2012 | 77.0% | +1.3% |
| 2013 | 83.0% | +7.8% |
| 2014 | 83.0% | +0.0% |
| 2015 | 82.0% | -1.2% |
| 2016 | 82.0% | +0.0% |
| 2017 | 78.0% | -4.9% |
| 2018 | 75.0% | -3.8% |
| 2019 | 66.0% | -12.0% |
| 2020 | 61.0% | -7.6% |
| 2021 | 65.0% | +6.6% |
| 2022 | 70.0% | +7.7% |
| 2023 | 74.0% | +5.7% |
| 2024 | 67.0% | -9.5% |
Laos compared with similar countries
- Laos's 67.0% is below the median for lower middle income countries, which is 84.0%, 80% of the median. (47 countries reporting)
- Laos's 67.0% is below the median for East Asia & Pacific, which is 93.0%, 72% of the median. (29 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 77.6% | 66.0% | 83.0% | 10 |
| 2020s | 67.4% | 61.0% | 74.0% | 5 |
Countries ranked near Laos
- 171 Chad 68.0% compare
- 171 Equatorial Guinea 68.0% compare
- 171 Guinea-Bissau 68.0% compare
- 174 Nigeria 67.0% compare
- 176 Democratic Republic of Congo 65.0% compare
- 177 Angola 64.0% compare
More health data for Laos
- Un projection of annual infant deaths, annual growth rate -2.76 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5667 % change on previous year (2090)
- Un projection of annual infant deaths 317 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 15 (2025)
- Population ages 00-04, female, annual growth rate -0.5161 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0489 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5055 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0511 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in Laos?
- Immunization, hib3 in Laos was 67.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Laos?
- The highest recorded value was 83.0% in 2013.
- What is the lowest immunization, hib3 recorded in Laos?
- The lowest recorded value was 61.0% in 2020.
- How does Laos rank for immunization, hib3?
- Laos ranks 174th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Laos?
- Over the last ten years it is down 19.3%. The long-run trend across the full record is falling.
- Where does this Laos data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.